The JenaValve ALIGN-AR Pivotal Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 180 participants.
Also called NCT04415047
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT04415047
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04415047. Allocation not applicable; no masking; primary purpose treatment. Start 2020-05-22 (actual); primary completion 2023-08-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The JenaValve ALIGN-AR Pivotal Trial
- Acronym
- ALIGN-AR
- Condition
- Aortic Regurgitation
- Condition
- Aortic Valve Insufficiency
- Condition
- Aortic Insufficiency
- Condition
- Aortic Valve Disease
- Intervention (Device)
- JenaValve Trilogy Heart Valve System
- Lead sponsor
- JenaValve Technology, Inc.
Record details
- Record id
cardio:ct-nct04415047- Content hash
c18f7e3c2c464c78197c365ef79b9d91a54fc2836bdf477c7005456b1e83c144